YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 0.627 USD -24.46% Market Closed
Market Cap: 25.8m USD

Operating Margin
YS Biopharma Co Ltd

-8.1%
Current
-21%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-8.1%
=
Operating Profit
-49.6m
/
Revenue
615m

Operating Margin Across Competitors

No Stocks Found

YS Biopharma Co Ltd
Glance View

Market Cap
25.8m USD
Industry
Biotechnology

YS Biopharma Co. Ltd. operates as a biopharmaceutical company, which is dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company is headquartered in Beijing, Beijing. The firm's vaccine product YSJATM rabies vaccine has been commercialized. The firm also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

LSB Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-8.1%
=
Operating Profit
-49.6m
/
Revenue
615m
What is the Operating Margin of YS Biopharma Co Ltd?

Based on YS Biopharma Co Ltd's most recent financial statements, the company has Operating Margin of -8.1%.

Back to Top